Assessment of the degree of diabetic neuropathy of the optic nerve following intravitreal interventions in proliferative diabetic retinopathy
DOI:
https://doi.org/10.31288/oftalmolzh201622833Keywords:
proliferative diabetic retinopathy, intravitreal interventions, optic nerve head neuropathy, visual evoked potentialAbstract
Purpose: To determine prospectively whether there is any relationship between a number of clinical factors and the degree of neuropathy of the optic nerve (ON) following intravitreal interventions in proliferative diabetic retinopathy (PDR).
Materials and Methods: One hundred and five patients (105 eyes) with good anatomic results after undergoing vitrectomy were followed up and underwent visual evoked potential (VEP) testing at 2 months and 12 months.
Results: At 2 months, neuropathy of the ON was observed in 56.1% of cases. Additionally, in 20.5% of these eyes, it was profound and characterized by intensely pale optic nerve head (ONH). At 12 months, the degree of neuropathy of the ON did not change. The functional activity of the visual system revealed by VEP tests (with 12-Hz flash, 1° and 0°15? checks) in study eyes was approximately 2-fold lower than normal values. Additionally, at both follow-up time points, the changes in VEP indices in eyes operated on for macular traction detachment were evidence of statistically significantly more profound degenerative processes in the nerve tissue than in eyes operated on for vitreous hemorrhage only.
Conclusions: Progressive proliferative diabetic retinopathy is accompanied by a progressive neurodegenerative process in the retina and in the optic nerve, resulting in the development of a profound neuropathy of the optic nerve. The findings advocate the need for intensive neuroprotective therapy as well for as early as possible intravitreal intervention in this category of patients.
References
Congdon N, O'Colmain B, Klaver CC et al; Eye Diseases Prevalence Research Group. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol. 2004 Apr;122(4):477-85.https://doi.org/10.1001/archopht.122.4.477
Barber AJ. A new view of diabetic retinopathy: a neurodegenerative disease of the eye. Prog Neuropsychopharmacol Biol Psychiatry. 2003 Apr;27(2):283-90.https://doi.org/10.1016/S0278-5846(03)00023-X
Sim? R, Hern?ndez C, European Consortium for the Early Treatment of Diabetic Retinopathy (EUROCONDOR). Neurodegeneration in the diabetic eye: new insights and therapeutic perspectives. Trends Endocrinol Metab. 2014 Jan;25(1):23-33.https://doi.org/10.1016/j.tem.2013.09.005
Veselinovi D, Jovanovi M. Diabetes mellitus and optic nerve diseases. Acta Fac Med Naiss. 2005;22:145-1481.
Abu El-Asrar AM, Dralands L, Missotten L et al. Expression of apoptosis markers in the retinas of human subjects with diabetes. Invest Ophthalmol Vis Sci. 2004 Aug;45(8): 2760-6.
Chopra D, Gupta M, Manchanda KC et al. A study of visual evoked potentials in patients of type 2 diabetes mellitus. JCDR. 2011;5:519-522.
Costache D, Damian C, Ianc?u M. The visual evoked potentials in diabetic retinopathy. Oftalmologia. 2004;48(1):53-7.
Matanovic D, Popovic S, Parapid B. Influence of the metabolic control on latency values of visual evoked potentials (VEP) in patients with diabetes mellitus type 1. Arch Ital Biol. 2012 Dec;150(4):251-8.
Heravian J, Ehyaei A, Shoeibi N et al. Pattern Visual Evoked Potentials in Patients with Type II Diabetes. J Ophthalmic Vis Res. 2012 Jul;7(3):225-30.
Wu de Zheng, Liu Yan. Atlas of Testing and Clinical Application for ROLAND Electrophysiological Instrument. Beijing Science and Technology Press, 2006. 174
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Элхадж Эмхамед Али, А. А. Путиенко
This work is licensed under a Creative Commons Attribution 4.0 International License.
This work is licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) that allows users to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author as long as they cite the source.
COPYRIGHT NOTICE
Authors who publish in this journal agree to the following terms:
- Authors hold copyright immediately after publication of their works and retain publishing rights without any restrictions.
- The copyright commencement date complies the publication date of the issue, where the article is included in.
DEPOSIT POLICY
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) during the editorial process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work with an acknowledgement of its initial publication in this journal.
- Post-print (post-refereeing manuscript version) and publisher's PDF-version self-archiving is allowed.
- Archiving the pre-print (pre-refereeing manuscript version) not allowed.
